The Sofia 2 Flu + SARS Antigen FIA employs immunofluorescence technology in a sandwich design that is used with Sofia 2 to detect nucleocapsid protein from influenza A, influenza B, and SARS-CoV-2. This test allows for the detection of SARS-CoV and SARS-CoV-2, but does not differentiate between the two viruses.
Published February 21, 2024 · Recall initiated: January 3, 2024
Summary
FDA records medical device Class II recall Z-1086-2024, published February 21, 2024 and initiated January 3, 2024. Recalling firm: Quidel Corporation; Status: Ongoing; Reported quantity: 312 Kits; Lot: UDI-DI: 30014613339229. Lot: 709083. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
One lot of the Sofia 2 Flu + SARS Antigen FIA (Lot 709083) was labelled with incorrect expiration dates. The kits contain pouched cassettes labeled with an expiration date of May 31, 2025, however the correct expiration date for the pouches is September 12, 2024. The kits are labeled with an expiration date of April 30, 2025, however, the correct expiration date for the kits is September 12, 2024. The issue was discovered on November 28, 2023 by a supply chain employee who determined that the kits had expiration dates beyond the FDA authorized shelf life.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Quidel Corporation
- Distributor
- US Nationwide distribution in the states of FL, TN, IL, LA, NY, IN.
- Lot
- UDI-DI: 30014613339229. Lot: 709083
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDAQuickVue Dipstick Strep A Test, 50T, REF 20108, antigens, all groups, streptococcus spp.May 20, 2026
- FDAQUIDEL InflammaDry MMP-9 Test, REF: PRS-ID-20, 20 TestsMay 1, 2024
- FDAQUIDEL InflammaDry MMP-9 Test, REF: PRS-ID-20-U, 20 TestsMay 1, 2024
- FDAStryker Neurovascular, Trevo Trak 21 Microcatheter, REF 90338, 0.021in X162cmFebruary 21, 2024
- FDACombiDiagnost R90 1.0 (709030)February 21, 2024
- FDAInflammaDry(R) AN RPS DIAGNOSTIC SOLUTION, Sample Collectors InflammaDry(R) is a rapid, immunoassay test forAugust 9, 2017
Questions about this recall
Was The Sofia 2 Flu + SARS Antigen FIA employs immunofluorescence technology in a sandwich design that is used with Sofia 2 to detect nucleocapsid protein from influenza A, influenza B, and SARS-CoV-2. This test allows for the detection of SARS-CoV and SARS-CoV-2, but does not differentiate between the two viruses. recalled?
Yes. FDA published recall Z-1086-2024 on February 21, 2024. Reported hazard: One lot of the Sofia 2 Flu + SARS Antigen FIA (Lot 709083) was labelled with incorrect expiration dates. The kits contain pouched cassettes labeled with an expiration date of May 31, 2025, however the correct expiration date for the pouches is September 12, 2024. The kits are labeled with an expiration date of April 30, 2025, however, the correct expiration date for the kits is September 12, 2024. The issue was discovered on November 28, 2023 by a supply chain employee who determined that the kits had expiration dates beyond the FDA authorized shelf life.
What should I do if I have this product?
Voluntary: Firm initiated · Letter